Floatz logo

Arachidyl amido cholanoic acid

Gallstones

Galmed Pharmaceuticals LtdSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Gallstones cohort.

Same molecule, other indications

Arachidyl amido cholanoic acid is also rated in:

metabolic dysfunction-associated steatohepatitisDormant
BB
Indicative ·
68 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
B
Indicative ·
60 / 100
View asset →
liver disorderDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →